Epilamba Junior shortlisted for the CPHI Pharma Awards 2026

Epilamba Junior by Cor.Con. International has been shortlisted as a finalist for the CPHI Pharma Awards 2026 in the Finished Formulation category.

Epilepsia

Sistema Nervioso Central

Ginecología

Defensa Inmunitaria

Cardiovascular

Sistema Metabólico

Bienestar del Consumidor